News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Peter Alagona Jr, MD, FACC

Articles by Peter Alagona Jr, MD, FACC

Beyond LDL Cholesterol: The Role of Elevated Triglycerides and Low HDL Cholesterol in Residual CVD Risk Remaining After Statin Therapy

ByPeter Alagona Jr, MD, FACC

March 27th 2009

Introduction

ByPeter Alagona Jr, MD, FACC,Mark J. Cziraky, PharmD, CLS, FAHA

March 27th 2009

Latest Updated Articles

Beyond LDL Cholesterol: The Role of Elevated Triglycerides and Low HDL Cholesterol in Residual CVD Risk Remaining After Statin Therapy
Published: March 27th 2009 | Updated:
Introduction
Published: March 27th 2009 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

Real-World Evidence Backs Acalabrutinib in CLL Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text